Aisling Capital Management as of Sept. 30, 2025
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 14 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 69.3 | $316M | 6.1M | 51.94 | |
| Verona Pharma Sponsored Ads (VRNA) | 14.4 | $66M | 615k | 106.71 | |
| Syndax Pharmaceuticals (SNDX) | 4.4 | $20M | 1.3M | 15.39 | |
| Nuvation Bio Com Cl A (NUVB) | 2.4 | $11M | 3.0M | 3.70 | |
| Monte Rosa Therapeutics (GLUE) | 2.4 | $11M | 1.5M | 7.41 | |
| Bicara Therapeutics (BCAX) | 2.0 | $9.0M | 569k | 15.79 | |
| Compass Pathways Sponsored Ads (CMPS) | 1.5 | $6.9M | 1.2M | 5.73 | |
| BridgeBio Oncology Therapeutics Com New | 1.4 | $6.5M | 565k | 11.58 | |
| Biomea Fusion (BMEA) | 0.9 | $4.1M | 2.0M | 2.02 | |
| Scholar Rock Hldg Corp (SRRK) | 0.6 | $2.9M | 77k | 37.24 | |
| CalciMedica Com New (CALC) | 0.4 | $1.6M | 521k | 3.08 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $826k | 435k | 1.90 | |
| Marker Therapeutics Com New (MRKR) | 0.1 | $290k | 325k | 0.89 | |
| OnKure Therapeutics Com Cl A (OKUR) | 0.1 | $244k | 89k | 2.75 |
